The war on vaping products is still raging and vapers and industry supporters are still doing their best to fight back. A new e-cig study revealed that vaping does not attract non-smokers as previously claimed. Take a look at the results of the study.
E-cig study in EU finds little use by non-smokers
An e-cig study that took a look at the use of electronic cigarettes and vaporizers in the European Union revealed that non-smokers rarely use them and that 67 percent of smokers who do use them either quit or smoked fewer traditional cigarettes. The study was led by researcher Dr. Konstantinos Farsalinos of the University of Patras in Greece. The study involved 27,460 EU residents at least 16 years of age. The participants were representatives from all 28 member states. The e-cig study was published in the journal Addiction, which has a focus on the potential harm-reduction elements of e-cigs and vaporizers.
E-cigarette use in the European Union appears to be largely confined to current or former smokers, while current use and nicotine use by people who have never smoked is rare.
The researchers said in their conclusion.
The number of non-smokers who said that they vaped was 2.3 percent of the study participants.The study found that 35.1 percent of current e-cigarette users had stopped smoking regular cigarettes because of the devices, while another 32.2 percent reported smoking less.
Check out more details on Winston-Salem Journal.
The FDA’s Deeming Rule On Vapor Products Must Be Challenged
There’s an increase in the number of lawsuits against the U.S. Food and Drug Administration’s (FDA) final deeming rule on vapor products. The lawsuits are focusing on various aspects of the regulations such as violations of the Regulatory Flexibility Act and Administrative Procedure Act, infringement of freedom of speech under the First Amendment and encroachment of the Fifth Amendment’s due process clause.
A number of associations in support of vaping and vape products have come out in support of the lawsuits. The Smoke-Free Alternatives Trade Association (SFATA) supports the Right to Be Smoke-Free Coalition (RSF) who have filed a suit of their own challenging the FDA’s industry-crushing rule. One of the fundamental objections to the deeming rule is that the FDA lacks the authority to regulate vapor products in the absence of therapeutic claims. Many legal experts agree that the Tobacco Control Act was never intended to apply to vapor products.
Read more on this issue on Forbes.